These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20077027)

  • 21. Cancer stem cells and the cellular hierarchy in haematological malignancies.
    Johnsen HE; Kjeldsen MK; Urup T; Fogd K; Pilgaard L; Boegsted M; Nyegaard M; Christiansen I; Bukh A; Dybkaer K
    Eur J Cancer; 2009 Sep; 45 Suppl 1():194-201. PubMed ID: 19775618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease.
    Cuneo A; Balboni M; Piva N; Carli MG; Tomasi P; Previati R; Negrini M; Scapoli G; Spanedda R; Castoldi G
    Haematologica; 1994; 79(1):76-82. PubMed ID: 15378954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.
    Eaves C; Eaves A
    Blood Cells; 1994; 20(1):83-93; discussion 93-5. PubMed ID: 7994064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic myeloid leukemia stem cells.
    Kavalerchik E; Goff D; Jamieson CH
    J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplantation dynamics of the immune response to chronic myelogenous leukemia.
    DeConde R; Kim PS; Levy D; Lee PP
    J Theor Biol; 2005 Sep; 236(1):39-59. PubMed ID: 15967182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal and leukaemic stem cells.
    Bonnet D
    Br J Haematol; 2005 Aug; 130(4):469-79. PubMed ID: 16098060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A model of the interclonal interactions in chronic myeloleukemia].
    Mamaev NN; Gushchin VA
    Eksp Onkol; 1989; 11(3):22-5. PubMed ID: 2752939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment.
    Holtz M; Forman SJ; Bhatia R
    Cancer Res; 2007 Feb; 67(3):1113-20. PubMed ID: 17283145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction.
    Moore H; Li NK
    J Theor Biol; 2004 Apr; 227(4):513-23. PubMed ID: 15038986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of alpha-IFN on chronic myeloid leukemia (CML) hematopoiesis maintained in long-term cultures.
    Santucci MA; Zuffa E; Russo D; Testoni N; Buzzi M; Baccarani M; Tura S
    Bone Marrow Transplant; 1991; 7 Suppl 2():25. PubMed ID: 1878701
    [No Abstract]   [Full Text] [Related]  

  • 31. The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.
    Ren R
    Oncogene; 2002 Dec; 21(56):8629-42. PubMed ID: 12476309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of the blast phase of chronic granulocytic leukemia.
    Canellos GP
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):359-67. PubMed ID: 2182596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Granulopoiesis and cytogenetic studies in chronic myeloid leukemia: their correlation with the clinical stage of the disease].
    Bianchi de Di Risio CC; Labal de Vinuesa ML; Fernández J; Gronda M; Larripa I
    Sangre (Barc); 1988 Jun; 33(3):178-83. PubMed ID: 3175814
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant cell growth in advancing leukemia.
    Papaphilis AD
    Anticancer Res; 1992; 12(1):225-30. PubMed ID: 1567170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modeling of bone marrow--peripheral blood dynamics in the disease state based on current emerging paradigms, part I.
    Afenya EK; Ouifki R; Camara BI; Mundle SD
    Math Biosci; 2016 Apr; 274():83-93. PubMed ID: 26877072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of protocellular growth laws.
    Rocheleau T; Rasmussen S; Nielsen PE; Jacobi MN; Ziock H
    Philos Trans R Soc Lond B Biol Sci; 2007 Oct; 362(1486):1841-5. PubMed ID: 17472929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. About the discrete-continuous nature of a hematopoiesis model for Chronic Myeloid Leukemia.
    Gaudiano ME; Lenaerts T; Pacheco JM
    Math Biosci; 2016 Dec; 282():174-180. PubMed ID: 27816533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periodic haematological diseases: mystical entities or dynamical disorders?
    Milton JG; Mackey MC
    J R Coll Physicians Lond; 1989 Oct; 23(4):236-41. PubMed ID: 2685268
    [No Abstract]   [Full Text] [Related]  

  • 39. Control in dormancy or eradication of cancer stem cells: Mathematical modeling and stability issues.
    Djema W; Bonnet C; Mazenc F; Clairambault J; Fridman E; Hirsch P; Delhommeau F
    J Theor Biol; 2018 Jul; 449():103-123. PubMed ID: 29678688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An exact representation for the generating function for the Moolgavkar-Venzon-Knudson two-stage model of carcinogenesis with stochastic stem cell growth.
    Denes J; Krewski D
    Math Biosci; 1996 Jan; 131(2):185-204. PubMed ID: 8589544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.